Enhancing the QUAlity and Transparency Of health Research

Blog Archives

01/10/2021 Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension 12/10/2016 REporting recommendations for tumour MARKer prognostic studies (REMARK) 16/02/2016 RiGoR: reporting guidelines to address common sources of bias in risk model development 13/07/2015 Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders 27/06/2013 Recommendations for biomarker identification and qualification in clinical proteomics 17/06/2013 STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement

Blog archives

Latest guest blogger